RANI compared with SEPN: revenue, margins and what each company keeps, and the suppliers and customers both name

RANIRani Therapeutics Holdings, Inc.

Mkt capRevenueRevenue

SEPNSepterna, Inc.

Mkt capRevenueRevenue

Compare

RANIRani Therapeutics Holdings, Inc.

SEPNSepterna, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RANI1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±35.6%▼−0.23%×0.01

SEPN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.9%▲+22.93%×1.92

May 12 '26±9.9%▲+5.39%×0.55

= impliedRANI realized, solidSEPN realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

Q1 FY26

±8.3%

▼−3.58%

×0.43

Q3 FY25±25.7%▼−2.22%×0.09

RANIRani Therapeutics Holdings, Inc.

0.60▼−1.49%· post 0.60

Mkt cap$82.2MRevenue$2MQ2 FY26Revenue—

SEPNSepterna, Inc.

43.98▼−2.76%· post 43.98

ClosedOct 30 '26

Mkt cap$2.0BRevenue$27MQ2 FY26Revenue$46MFY25

Compare

ClosedOct 30 '26

RANIRani Therapeutics Holdings, Inc.

SEPNSepterna, Inc.

0.60▼−1.49%post 0.60

Price

43.98▼−2.76%post 43.98

$82.2M

Mkt cap

$2.0B

Q2 FY26$2M

Revenue

$27MQ2 FY26

—

Revenue

$46MFY25

RANI0.60▼−1.49%vsSEPN43.98▼−2.76%ClosedOct 30 '26